The valuation is basically whatever the note holders will accept and it will probably also include warrants or some kind of make whole provision to ensure they at least get their principal back before shareholders see a dime. That means shareholders will be screwed over.
In over 5 years since they acquired these assets, they have not generated any revenue. They abandoned all their clinical trials for traumatic brain injury and all other trials they were pursuing.
News 
Market Data 
Discover 
